Increases amount of cigarette and other tobacco products tax revenues provided to New Jersey Commission on Cancer Research to $10 million; establishes dedicated, non-lapsing Cancer Research Fund.
Impact
The bill's provisions will replace the current lapsing Cancer Research Fund with a non-lapsing, revolving fund, thus ensuring that the funding remains available year after year without being absorbed into the state's general fund. This structural change is expected to enhance the NJCCR's ability to provide grants and contracts for crucial research focusing on both adult and pediatric cancer. With specific allocations of at least $5 million each for general cancer research and pediatric cancer research, the bill emphasizes the importance of addressing disparities in cancer treatment access, particularly for minority and vulnerable populations in New Jersey.
Summary
Assembly Bill A4579 aims to significantly enhance the funding allocated to the New Jersey Commission on Cancer Research (NJCCR) by increasing the revenue generated from cigarette and other tobacco products taxes from $1 million to $10 million annually. This increased funding is intended to support a dedicated, non-lapsing Cancer Research Fund. The NJCCR will utilize these funds to finance various cancer research projects, focusing particularly on addressing the causes, prevention, and treatment of cancer while also serving as a valuable resource for information regarding cancer care.
Contention
There may be contention surrounding the bill with regard to how the increased tax revenues will be implemented and the implications for the tobacco industry. Some members of the community and stakeholders might argue about the socio-economic impacts of heightened tobacco taxes, particularly on low-income individuals who may be disproportionately affected. Furthermore, there could be discussions about the effectiveness of funneling these increased funds into existing frameworks rather than exploring new innovative approaches to tackle cancer research and treatment disparities.
Same As
Increases amount of cigarette and other tobacco products tax revenues provided to New Jersey Commission on Cancer Research to $10 million; establishes dedicated, non-lapsing Cancer Research Fund.
Carry Over
Increases amount of cigarette and other tobacco products tax revenues provided to New Jersey Commission on Cancer Research to $10 million; establishes dedicated, non-lapsing Cancer Research Fund.
Carry Over
Increases amount of cigarette and other tobacco products tax revenues provided to New Jersey Commission on Cancer Research to $10 million; establishes dedicated, non-lapsing Cancer Research Fund.